HMBA Enhances Prostratin-Induced Activation of Latent HIV-1 via Suppressing the Expression of Negative Feedback Regulator A20/TNFAIP3 in NF- B Signaling

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Chen, Duchu ^a   Wang, Huiping ^a,b   Aweya, Jude Juventus ^a   Chen, Yanheng ^a   Chen, Meihua ^a   Wu, Xiaomeng ^a   Chen, Xiaonan ^a   Lu, Jing ^a   Chen, Ruichuan ^a   Liu, Min ^a  

^a XIAMEN UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DEUBIQUITINASE; DEUBIQUITINASE A20; FLAVOPIRIDOL; HEXAMETHYLENEBISACETAMIDE; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL ESTER DERIVATIVE; PROSTRATIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETAMIDE DERIVATIVE; I KAPPA B; PHORBOL ESTER; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; TNFAIP3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NEGATIVE FEEDBACK; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION ELONGATION; TRANSCRIPTION INITIATION; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HIV INFECTIONS; PHOSPHORYLATION; PHYSIOLOGICAL FEEDBACK; PROVIRUS; VIROLOGY;

ACETAMIDES; DRUG SYNERGISM; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PHORBOL ESTERS; PHOSPHORYLATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROVIRUSES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR ALPHA-INDUCED PROTEIN 3;

EID: 84982182573     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/5173205     Document Type: Article

References (30)

1. Y. Han, M. Wind-Rotolo, H.-C. Yang, J. D. Siliciano, and R. F. Siliciano, "Experimental approaches to the study of HIV-1 latency, " Nature Reviews Microbiology, vol. 5, no. 2, pp. 95-106, 2007.
2. L. Colin and C. Van Lint, "Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies, " Retrovirology, vol. 6, article 111, 2009.
3. C. Van Lint, S. Bouchat, and A. Marcello, "HIV-1 transcription and latency: an update, " Retrovirology, vol. 10, no. 1, article 67, 2013.
4. R. F. Siliciano and W. C. Greene, "HIV latency, " Cold Spring Harbor Perspectives in Medicine, vol. 1, no. 1, Article IDa007096, 2011.
5. A. Shilatifard, "Transcriptional elongation control by RNA polymerase II: a new frontier, " Biochimica et Biophysica Acta- Gene Structure and Expression, vol. 1677, no. 1-3, pp. 79-86, 2004.
6. R. J. Sims III, R. Belotserkovskaya, and D. Reinberg, "Elongation by RNA polymerase II: the short and long of it, " Genes and Development, vol. 18, no. 20, pp. 2437-2468, 2004.
7. S. A. Williams, L.-F. Chen, H. Kwon et al., "Prostratin antagonizes HIV latency by activating NF-B, " Journal of Biological Chemistry, vol. 279, no. 40, pp. 42008-42017, 2004.
8. G. Jiang, E. A. Mendes, P. Kaiser et al., "Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation, " PLoS Pathogens, vol. 11, no. 7, Article ID e1005066, 2015.
9. G. Jiang, E. A. Mendes, P. Kaiser et al., "Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinaseC-NF-Bsignaling, " AIDS, vol. 28, no. 11, pp. 1555-1566, 2014.
10. G. Darcis, A. Kula, S. Bouchat et al., "An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression, " PLoS Pathogens, vol. 11, no. 7, Article IDe1005063, 2015.
11. R. Chen, M. Liu, H. Li et al., "PP2B and PP1 cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling, " Genes and Development, vol. 22, no. 10, pp. 1356-1368, 2008.
12. N. Ai, X. Hu, F. Ding et al., "Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation, " Nucleic Acids Research, vol. 39, no. 22, pp. 9592-9604, 2011.
13. X. Hu, X. Lu, R. Liu et al., "Histone cross-talk connects protein phosphatase 1 (PP1) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomaincontaining 4 (BRD4) for inducible gene expression, "TheJournal of Biological Chemistry, vol. 289, no. 33, pp. 23154-23167, 2014.
14. J. Zhu, G. D. Gaiha, S. P. John et al., "Reactivation of LatentHIV-1 by Inhibition of BRD4, " Cell Reports, vol. 2, no. 4, pp. 807-816, 2012.
15. D. Boehm, V. Calvanese, R. D. Dar et al., "BET bromodomaintargeting compounds reactivate HIV from latency via a Tatindependentmechanism, " Cell Cycle, vol. 12, no. 3, pp. 452-462, 2013.
16. J. Kulkosky, D. M. Culnan, J. Roman et al., "Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART, " Blood, vol. 98, no. 10, pp. 3006-3015, 2001.
17. Y. D. Korin, D. G. Brooks, S. Brown, A. Korotzer, and J. A. Zack, "Effects of prostratin on T-cell activation and human immunodeficiency virus latency, " Journal of Virology, vol. 76, no. 16, pp. 8118-8123, 2002.
18. R. J. Gulakowski, J. B. McMahon, R. W. Buckheit Jr., K. R. Gustafson, and M. R. Boyd, "Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV), " Antiviral Research, vol. 33, no. 2, pp. 87-97, 1997.
19. X.-N. Li, Z.-W. Du, and Q. Huang, "Modulation effects of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells, " Journal of Neurosurgery, vol. 84, no. 5, pp. 831-838, 1996.
20. P. A. Marks, V. M. Richon, and R. A. Rifkind, "Induced differentiation of cancer cells: second generation potent hybrid polar compounds target cell cycle regulators, " European Journal of Cancer Prevention, vol. 5, no. 2, pp. 75-77, 1996.
21. G.-L. Ouyang, Q.-F. Cai, M. Liu et al., "Growth arrest and apoptosis of human hepatocellular carcinoma cells induced by hexamethylene bisacetamide, " World Journal of Gastroenterology, vol. 10, no. 7, pp. 954-958, 2004.
22. V. Cecchinato, E. Erba, A. Basile et al., "Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines, " Leukemia Research, vol. 32, no. 5, pp. 791-797, 2008.
23. J. K. Chan and W. C. Greene, "Dynamic roles for NF-B in HTLV-I and HIV-1 retroviral pathogenesis, " Immunological Reviews, vol. 246, no. 1, pp. 286-310, 2012.
24. J. Ruland, "Return to homeostasis: downregulation of NF-B responses, " Nature Immunology, vol. 12, no. 8, pp. 709-714, 2011.
25. A. P. Fields, D. P. Bednarik, A. Hess, and W. S. May, "Human immunodeficiency virus induces phosphorylation of its cell surface receptor, " Nature, vol. 333, no. 6170, pp. 278-280, 1988.
26. A. Jordan, D. Bisgrove, and E. Verdin, "HIV reproducibly establishes a latent infection after acute infection of T cells in vitro, " EMBO Journal, vol. 22, no. 8, pp. 1868-1877, 2003.
27. R. Pearson, K. K. Young, J. Hokello et al., "Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency, " Journal of Virology, vol. 82, no. 24, pp. 12291-12303, 2008.
28. Z. Yang, Q. Zhu, K. Luo, and Q. Zhou, "The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription, " Nature, vol. 414, no. 6861, pp. 317-322, 2001.
29. A. Dey, E. Wong, N. Kua, L. T. Hsiang, V. Tergaonkar, and D. Lane, "Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF B activity: implications for cancer therapy, " Cell Cycle, vol. 7, no. 23, pp. 3759-3767, 2008.
30. S. Xing and R. F. Siliciano, "Targeting HIV latency: pharmacologic strategies toward eradication, " Drug Discovery Today, vol. 18, no. 11-12, pp. 541-551, 2013.